Canto J G, Every N R, Magid D J, Rogers W J, Malmgren J A, Frederick P D, French W J, Tiefenbrunn A J, Misra V K, Kiefe C I, Barron H V
Department of Medicine, and Center for Outcomes and Effectiveness Research and Education, University of Alabama at Birmingham, 35294-0012, USA.
N Engl J Med. 2000 May 25;342(21):1573-80. doi: 10.1056/NEJM200005253422106.
There is an inverse relation between mortality from cardiovascular causes and the number of elective cardiac procedures (coronary angioplasty, stenting, or coronary bypass surgery) performed by individual practitioners or hospitals. However, it is not known whether patients with acute myocardial infarction fare better at centers where more patients undergo primary angioplasty or thrombolytic therapy than at centers with lower volumes.
We analyzed data from the National Registry of Myocardial Infarction to determine the relation between the number of patients receiving reperfusion therapy (primary angioplasty or thrombolytic therapy) and subsequent in-hospital mortality. A total of 450 hospitals were divided into quartiles according to the volume of primary angioplasty. Multiple logistic-regression models were used to determine whether the volume of primary angioplasty procedures was an independent predictor of in-hospital mortality among patients undergoing this procedure. Similar analyses were performed for patients receiving thrombolytic therapy at 516 hospitals.
In-hospital mortality was 28 percent lower among patients who underwent primary angioplasty at hospitals with the highest volume than among those who underwent angioplasty at hospitals with the lowest volume (adjusted relative risk, 0.72; 95 percent confidence interval, 0.60 to 0.87; P<0.001). This lower rate, which represented 2.0 fewer deaths per 100 patients treated, was independent of the total volume of patients with myocardial infarction at each hospital, year of admission, and use or nonuse of adjunctive pharmacologic therapies. There was no significant relation between the volume of thrombolytic interventions and in-hospital mortality among patients who received thrombolytic therapy (7.0 percent for patients in the highest-volume hospitals vs. 6.9 percent for those in the lowest-volume hospitals, P=0.36).
Among hospitals in the United States that have full interventional capabilities, a higher volume of angioplasty procedures is associated with a lower mortality rate among patients undergoing primary angioplasty, but there is no association between volume and mortality for thrombolytic therapy.
心血管疾病导致的死亡率与个体从业者或医院进行的择期心脏手术(冠状动脉血管成形术、支架置入术或冠状动脉搭桥手术)数量之间存在反比关系。然而,尚不清楚急性心肌梗死患者在接受直接血管成形术或溶栓治疗的患者数量较多的中心是否比在治疗量较低的中心预后更好。
我们分析了国家心肌梗死登记处的数据,以确定接受再灌注治疗(直接血管成形术或溶栓治疗)的患者数量与随后的住院死亡率之间的关系。根据直接血管成形术的治疗量,将450家医院分为四分位数。使用多个逻辑回归模型来确定直接血管成形术的治疗量是否是接受该手术患者住院死亡率的独立预测因素。对在516家医院接受溶栓治疗的患者进行了类似分析。
在治疗量最高的医院接受直接血管成形术的患者,其住院死亡率比在治疗量最低的医院接受血管成形术的患者低28%(调整后的相对风险为0.72;95%置信区间为0.60至0.87;P<0.001)。这种较低的死亡率相当于每100例接受治疗的患者中死亡人数减少2.0例,这与每家医院心肌梗死患者的总数、入院年份以及是否使用辅助药物治疗无关。在接受溶栓治疗的患者中,溶栓干预的治疗量与住院死亡率之间没有显著关系(治疗量最高的医院患者为7.0%,治疗量最低的医院患者为6.9%,P=0.36)。
在美国具备全面介入能力的医院中,较高的血管成形术治疗量与接受直接血管成形术患者的较低死亡率相关,但治疗量与溶栓治疗的死亡率之间没有关联。